Breast Implant Link to Rare T-Cell Lymphoma an Ongoing Concern
Kristin Jenkins, February 06, 2019
More cases of a rare T-cell lymphoma associated with breast implants have been reported, says the US Food and Drug Administration (FDA).
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) can develop in the capsule around a silicone gel- or saline-filled implant used in breast reconstruction after mastectomy or in cosmetic breast augmentation. The average lag time between surgery and diagnosis is 9.2 years.
Click HERE for the full article on Medscape.